期刊文献+

复发性脑梗死不同TOAST分型的危险因素分析

Analysis on risk factors for different recurrent cerebral infarction subtypes according to the TOAST criteria
下载PDF
导出
摘要 目的分析复发性脑梗死患者不同TOAST分型危险因素的差别。方法将2009年4月~2010年4月间在山西医科大学第一医院神经内科住院的复发性脑梗死患者连续入组,收集各住院患者相关的临床资料,记录各项相关辅助检查结果数据,并对其各项研究内容予以赋值。按照TOAST标准将住院患者分为五个亚型,比较各亚型导致复发的相关因素之间的差别。结果复发性脑梗死TOAST各亚型构成比例为:大动脉粥样硬化型(LAA)20.2%,心源性栓塞型(CE)14.4%,小动脉闭塞型(SAA)27.1%,其他明确病因型(SOE)3.2%,不明原因型(SUE)35.1%。高血压、脂代谢异常、纤维蛋白原含量在各亚型间比较差异有统计学意义(P〈0.05),前两者在大动脉粥样硬化型组(LAA)所占比例最高。结论在复发性脑梗死TOAST5个亚型间比较,高血压、脂代谢异常在大动脉粥样硬化型组(LAA)所占比例最高,纤维蛋白原水平LAA组亦高于其他组,提示高血压、脂代谢异常、纤维蛋白原水平在该组的复发中起到更为重要的作用。 Objective To analysis the difference of risk factors for recurrent cerebral infarction subtypes according to the TOAST criteria. Methods Data were collected prospectively from consecutive recurrent ischemic stroke inpatients in the Department of Neurology of the First Hospital of Shanxi Medical University from April 2009 to April 2010. After completing medical records and auxiliary diagnostic studies, all included patients were classified into 5 major ischemic stroke subtypes based on TOAST criteria. The difference of the factors were compared among different subtypes of recurrent cerebral infarction. Results The proportion of ischemic stroke subtype according to TOAST criteria was as follows:large-artery atherosclerosis(LAA)20.2%, cardioembolism(CE)14.4%, small-artery occlusion lacunar (SAA) 27.1%, stroke of other demonstrated etiology(SOE)3.2%, stroke of undetermined etiology (SUE) 35.1%. The proportions of hypertension, lipid metabolism disorder and fibrinogen had statistic differences among the 5 groups(P〈0.05). The highest proportions of hypertension and lipid metabolism disorder were seen in large-artery atherosclerosis(LAA)patients compared to the others. Conclusions In the comparison among the 5 groups, the highest proportions of hypertension and lipid metabolism disorder are seen in LAA patients. The fibrinogen concentration in LAA group is also higher compared with that in others(P〈0.05).Hypertension, lipid metabolism disorder and fibrinogen concentration may play more important roles in the recurrence of LAA.
作者 尹楠 郭军红
出处 《中国现代药物应用》 2013年第19期4-6,共3页 Chinese Journal of Modern Drug Application
关键词 脑梗死 复发 危险因素 TOAST分型 Cerebral infarction Recurrence Risk factors TOAST classification
  • 相关文献

参考文献16

  • 1梁玉宏,张小琳.卒中预后的预测因素[J].国外医学(脑血管疾病分册),1993,1(3):155-158. 被引量:38
  • 2Adams HP Jr, Bendixen BH,Kappelle LJ, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial.TOAST.TriM of Org 10172 in Acute Stroke Treatment. Stroke, 1993, (24):35-41.
  • 3Kristensen B, Maim J, Carlberg B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden.S troke,1997, (28): 1702-1709.
  • 4Lee BI, Nam HS, Hen JH, et al. Yonsei stroke registry: analysis of 1000 patients with acute cerebral infarction.Cereborvasc Dis, 2001,(12) :145 -151.
  • 5Amann K,Rump LC, Simonaviciene A, et al.Effects of low dose sympathetic inhibition on glomendosclerosis and albuminuria in subtotally nep rats. J Am Soc NephroL 2000, (11):1469-1478.
  • 6Zoccali C,Mallamaci F,Parlongo S,et al.Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation, 2002, (105): 1354-1359.
  • 7Lai S M,Aher M,Friday G,et al.A multifactorial analysis of risk factors for recurrence of ischemic stroke.Stroke.1994, 25(5):958-962.
  • 8Alter M,Friday G,Lai S M,et al.Hypertension and risk of stroke recurrence. Stroke. 1994,25(8):1605-1610.
  • 9严毓勤,徐济民.高血压病的流行现状及治疗进展[J].上海预防医学,2003,15(5):208-209. 被引量:12
  • 10郭文涛,齐智慧,庞长绪.原发性高血压患者血压控制与脑梗死复发率的关系[J].中国实用神经疾病杂志,2007,10(4):72-73. 被引量:7

二级参考文献23

  • 1洪雁.缺血性脑血管病复发的危险因素分析(附691例报告)[J].广西医学,2005,27(6):824-826. 被引量:5
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 3薛万友.原发性高血压病合并无症状性脑梗死56例临床分析[J].中国实用神经疾病杂志,2006,9(6):77-77. 被引量:1
  • 4季燕,王建平,宋玉丽,詹三华,刘红斌,马秀英.高血压、细胞因子与脑梗死的相关性探讨[J].中国实用神经疾病杂志,2006,9(5):73-74. 被引量:7
  • 5[7]Hier DB,Foulkes MA,Swiontoniouski M.Stroke recurrence within 2 years after ischemic infarction[J].Stroke,1991,22(1):155~161
  • 6Ferrari P, Ferrandi M, Tripodi L, et al. PST2238: a new antihypertensive compound that modulates Na^+, K^+ - ATPase in genetic hypertension[J] .J Pharm Exp Ther, 1999, 288:1074-1083.
  • 7Ian M, Phillips SM, Galli. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease[ J ]. Drugs, 2000, 60 (2) : 239-248.
  • 8Kendall M J, Toeseu V. The HOT Study. Hypertension Optimal Therapy[J], J Clin Pharm Ther, 1998, 23(2) : 137-139,.
  • 9Hunt KJ, Evans GW, Folsom AIR, et al. Acoustic shadowing on B-mode ultrasound of the carotid artery predicts ischemic stroke: the Atherosclerosis Risk in Communities(ARIC) study. Stroke, 2001, 32(5):1120 -1126.
  • 10Magyar MT, Szikszai Z, Balla J, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke, 2003, 34 (1):58-63.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部